Notch4 is required for tumor onset and perfusion

Vascular Cell

Volumn 5, Issue 1, 2013, Pages

  Costa, Maria José ^a,c   Wu, Xiaoqing ^a,d   Cuervo, Henar ^a   Srinivasan, Ruchika ^a,e   Bechis, Seth K ^a,f   Cheang, Ellen ^a,g   Marjanovic, Olivera ^a,h   Gridley, Thomas ^b   Cvetic, Christin A ^a   Wang, Rong A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Maine Medical Center Research Institute   (United States)

^c STANFORD UNIVERSITY   (United States)

^d TechData Services Company   (United States)

^e NOVARTIS HEALTHCARE PVT LTD   (India)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Blood vessel; Notch; Perfusion; Tumor

Indexed keywords

NOTCH4 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER SIZE; FEMALE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UPREGULATION;

MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 84877005234     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-5-7     Document Type: Article

References (32)

1. Notch signaling: the core pathway and its posttranslational regulation. Fortini ME, Dev Cell 2009 16 5 633 647 10.1016/j.devcel.2009.03.010 19460341
2. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J, Development 1996 122 7 2251 2259 8681805 (Pubitemid 26235824)
3. Notch signaling is essential for vascular morphogenesis in mice. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Genes Dev 2000 14 11 1343 1352 10837027 (Pubitemid 30397078)
4. Notch1 is essential for postimplantation development in mice. Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T, Genes Dev 1994 8 6 707 719 10.1101/gad.8.6.707 7926761 (Pubitemid 24116765)
5. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Takeshita K, Satoh M, Ii M, Silver M, Limbourg FP, Mukai Y, Rikitake Y, Radtke F, Gridley T, Losordo DW, Circ Res 2007 100 1 70 78 10.1161/01.RES.0000254788. 47304.6e 17158336 (Pubitemid 46066775)
6. Tumor angiogenesis: therapeutic implications. Folkman J, N Engl J Med 1971 285 21 1182 1186 10.1056/NEJM197111182852108 4938153
7. Notch signaling in developmental and tumor angiogenesis. Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, Kitajewski J, Genes Cancer 2011 2 12 1106 1116 10.1177/1947601911423030 22866202
8. Angiogenesis: a team effort coordinated by notch. Phng LK, Gerhardt H, Dev Cell 2009 16 2 196 208 10.1016/j.devcel.2009.01.015 19217422
9. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G, Nature 2006 444 7122 1032 1037 10.1038/nature05355 17183313 (Pubitemid 46018516)
10. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I, Nature 2006 444 7122 1083 1087 10.1038/nature05313 17183323 (Pubitemid 46018529)
11. Therapeutic antibody targeting of individual Notch receptors. Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, Nature 2010 464 7291 1052 1057 10.1038/nature08878 20393564
12. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. Braren R, Hu H, Kim YH, Beggs HE, Reichardt LF, Wang R, J Cell Biol 2006 172 1 151 162 10.1083/jcb.200506184 16391003 (Pubitemid 43042637)
13. Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA, Lab Invest 2009 89 9 971 982 10.1038/labinvest.2009.62 19546852
14. MET and MYC cooperate in mammary tumorigenesis. Welm AL, Kim S, Welm BE, Bishop JM, Proc Natl Acad Sci USA 2005 102 12 4324 4329 10.1073/pnas.0500470102 15738393 (Pubitemid 40397110)
15. A new mathematical model for relative quantification in real-time RT-PCR. Pfaffl MW, Nucleic Acids Res 2001 29 9 45 10.1093/nar/29.9.e45 11328886
16. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM, J Cell Biol 2001 153 5 1023 1034 10.1083/jcb.153.5.1023 11381087 (Pubitemid 34289241)
17. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Genome Biol 2007 8 5 76 10.1186/gb-2007-8-5-r76 17493263 (Pubitemid 351902765)
18. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Guy CT, Cardiff RD, Muller WJ, Mol Cell Biol 1992 12 3 954 961 1312220
19. Vascular remodelling during the normal and malignant life cycle of the mammary gland. Djonov V, Andres AC, Ziemiecki A, Microsc Res Tech 2001 52 2 182 189 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.0.CO;2-M 11169866 (Pubitemid 32107806)
20. Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, Fodinger D, Tschachler E, FASEB J 2007 21 14 3994 4004 10.1096/fj.07-8720com 17625068 (Pubitemid 350232356)
21. Expression of notch receptors, notch ligands, and fringe genes in hematopoiesis. Singh N, Phillips RA, Iscove NN, Egan SE, Exp Hematol 2000 28 5 527 534 10.1016/S0301-472X(00)00146-6 10812242 (Pubitemid 30254453)
22. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Brem SS, Gullino PM, Medina D, Science 1977 195 4281 880 882 10.1126/science.402692 402692 (Pubitemid 8048148)
23. Recent insights into the role of Notch signaling in tumorigenesis. Leong KG, Karsan A, Blood 2006 107 6 2223 2233 10.1182/blood-2005-08-3329 16291593 (Pubitemid 43345539)
24. Notch signalling in solid tumours: a little bit of everything but not all the time. Ranganathan P, Weaver KL, Capobianco AJ, Nat Rev Cancer 2011 11 5 338 351 10.1038/nrc3035 21508972
25. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB, Cancer Res 2010 70 2 709 718 10.1158/0008-5472.CAN- 09-1681 20068161
26. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A, Mol Cancer 2009 8 128 10.1186/1476-4598-8-128 20030805
27. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, Ersahin C, Rajan P, Int J Surg Pathol 2012 20 2 139 145 22084425
28. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Sun Y, Lowther W, Kato K, Bianco C, Kenney N, Strizzi L, Raafat D, Hirota M, Khan NI, Bargo S, Oncogene 2005 24 34 5365 5374 10.1038/sj.onc.1208528 16007227 (Pubitemid 43080106)
29. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R, Am J Pathol 2010 176 4 2019 2028 10.2353/ajpath.2010.090908 20167860
30. Basic and therapeutic aspects of angiogenesis. Potente M, Gerhardt H, Carmeliet P, Cell 2011 146 6 873 887 10.1016/j.cell.2011.08.039 21925313
31. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Blood 2007 109 11 4753 4760 10.1182/blood-2006-12-063933 17311993 (Pubitemid 46827768)
32. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Hanahan D, Coussens LM, Cancer Cell 2012 21 3 309 322 10.1016/j.ccr.2012.02.022 22439926